Results 11 to 20 of about 2,749,776 (308)

Identification of signaling pathways in early mammary gland development by mouse genetics [PDF]

, 2004
The mammary gland develops as an appendage of the ectoderm. The prenatal stage of mammary development is hormone independent and is regulated by sequential and reciprocal signaling between the epithelium and the mesenchyme.
A Yang, AA Mailleux, AA Mill, C van Genderen, DL Chapman, GW Robinson, H van Bokhoven, J Foley, J Laurikkala, J Laurikkala, JJ Wysolmerski, JJ Wysolmerski, JM Veltmaat, JM Veltmaat, L Hennighausen, M Bamshad, ME Dunbar, OT Oftedal, T Andl, T Mustonen, TG Davenport   +20 more
core   +2 more sources

Overdiagnosis and overtreatment of breast cancer: Overdiagnosis in randomised controlled trials of breast cancer screening [PDF]

, 2005
Data from randomised controlled trials of mammographic screening can be used to determine the extent of any overdiagnosis, as soon as either a time equivalent to the lead-time has elapsed after the final screen, or the control arm has been offered ...
AB Miller, AB Miller, AB Miller, AB Miller, FE Alexander, FE Alexander, H Vainio, I Andersson, J Frisell, L Tabar, MF Yen, N Bjurstam, S Moss, S Moss, S Shapiro, S Shapiro, Sue Moss, SW Duffy, The Breast Screening Frequency Trial Group   +18 more
core   +3 more sources

Family history of breast and ovarian cancer and triple negative subtype in hispanic/latina women. [PDF]

, 2014
Familial breast and ovarian cancer prevalence was assessed among 1150 women of Mexican descent enrolled in a case-only, binational breast cancer study. Logistic regression was conducted to compare odds of triple negative breast cancer (TNBC) to non-TNBC ...
Anderson, Kristin, Bondy, Melissa, Brewster, Abenaa, Daneri-Navarro, Adrian, Gutierrez-Millan, Luis Enrique, Komenaka, Ian K, Madlensky, Lisa, Martin, Lorena, Martínez, María Elena, Meza-Montenegro, Maria Mercedes, Natarajan, Loki, Thompson, Patricia A, Tobias, Malaika, Wertheim, Betsy C   +13 more
core   +2 more sources

Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer (2024 edition) [PDF]

Zhongguo aizheng zazhi
In China, 60% of breast cancer patients were premenopausal women at the time of diagnosis. Compared with postmenopausal women, premenopausal women have strong ovarian function and secrete estrogen to promote breast cancer growth.
Committee of Breast Cancer Society, China Anti-Cancer Association
doaj   +1 more source

Breast tumor diagnosis in digital mammograms [PDF]

, 2019
Breast cancer has been classified as the most common cancer in most part of the world [1]. Breast cancer is caused by the growth of the abnormal cells in the breast. Breast cancer not only develops in women but also on men.
Gaik Tay, Kim, Huong, Audrey, Yang Lim, Xiang   +2 more
core   +1 more source

Increased prevalence of colorectal adenomas in women with breast cancer [PDF]

, 2005
Background: The frequency of colorectal adenomas and carcinomas was investigated in a large cohort of women with breast cancer in comparison with matched controls, since data on the occurrence of second tumors in women with breast cancer is controversial.
Bayerdörffer, Ekkehard, Eiermann, Wolfgang, Göke, Burkhard, Mannes, Gerd Alexander, Meining, Alexander, Ochsenkühn, Thomas, Sackmann, Michael, Späth, Lydia, Wiebecke, Baldur   +8 more
core   +1 more source

A family history of breast cancer will not predict female early onset breast cancer in a population-based setting [PDF]

, 2008
: BACKGROUND: An increased risk of breast cancer for relatives of breast cancer patients has been demonstrated in many studies, and having a relative diagnosed with breast cancer at an early age is an indication for breast cancer screening.
A Lucassen, A Ziogras, AE Guttmacher, Caroline Seynaeve, Catharina E Jacobi, Cecile TM Brekelmans, Cees J Cornelisse, Christi J van Asperen, CJ Van Asperen, CJ Van Asperen, Collaborative Group on Hormonal Factors in Breast Cancer, D Ford, D Steinmann, D Thompson, DA Berry, DM Eccles, DM Eccles, EB Claus, EB Claus, Elly MM Krol-Warmerdam, FE Harrell Jr, G Parmigiani, Geertruida H de Bock, H Eerola, Jan GM Klijn, Jannet Blom, Johannes C van Houwelingen, JP Klein, KF Hoskins, KL Nathanson, O Visser, PD Pharoah, Peter Devilee, R Gershoni-Baruch, Rob AEM Tollenaar, RW Blamey, The Breast Cancer Linkage Consortium   +36 more
core   +8 more sources

Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial

Nature Communications, 2023
Immunotherapy combined with chemotherapy has been demonstrated to be effective in early triple-negative breast cancer (TNBC). In this single-arm, phase II study with Simon’s two-stage design, we investigated the efficacy and safety of neoadjuvant ...
Chengzheng Wang, Zhenzhen Liu, Xiuchun Chen, Jianghua Qiao, Zhenduo Lu, Lianfang Li, Xianfu Sun, Chongjian Zhang, Xiayu Yue, Qingxin Xia, He Zhang, Min Yan   +11 more
doaj   +1 more source

Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer. [PDF]

, 2014
Preventing breast cancer is an effective strategy for reducing breast cancer deaths. The purpose of chemoprevention (also termed preventive therapy) is to reduce cancer incidence by use of natural, synthetic, or biological agents.
Brown, Powel H, Litzenburger, Beate C
core   +1 more source

High expression of Linc00959 predicts poor prognosis in breast cancer

Cancer Cell International, 2019
Background Accumulating studies have focused on the oncogenic roles of the newly identified lncRNAs in human cancers. The aim of this study was to examine the expression pattern of Linc00959 in BC and to evaluate its biological role and clinical ...
Weiru Chi, Sheng Huang, Bingqiu Xiu, Qi Zhang, Zhiming Shao, Jiong Wu, Yayun Chi   +6 more
doaj   +1 more source